Middleton, WI – According to filings with the U.S. Securities and Exchange Commission, Zurex Pharma is raising $15,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Carmine Durham played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Zurex Pharma

Zurex Pharma, Inc. is a specialty pharma and medical technology company with a novel antimicrobial technology platform. Our company’s mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent Health Care-Associated Infections with a focus on surgical site wounds and catheter-related infections. Our goal is to provide safe and effective anti-microbial products designed to reduce the risks associated with health care-associated infections with a focus on surgical site wounds and catheter-related bloodstream infections (CRBSI).

To learn more about Zurex Pharma, visit http://www.zurex-pharma.com/

Contact:
Carmine Durham, President and Chief Executive Officer
608-203-9090
https://www.linkedin.com/in/carmine-durham-bb88744a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved